Your browser is no longer supported. Please, upgrade your browser.
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E20.62 EPS (ttm)2.45 Insider Own26.40% Shs Outstand1.96B Perf Week6.35%
Market Cap99.29B Forward P/E19.53 EPS next Y2.59 Insider Trans0.00% Shs Float1.25B Perf Month3.04%
Income6.15B PEG2.48 EPS next Q0.61 Inst Own7.90% Short Float0.29% Perf Quarter20.64%
Sales18.19B P/S5.46 EPS this Y10.60% Inst Trans0.49% Short Ratio1.80 Perf Half Y38.34%
Book/sh3.11 P/B16.25 EPS next Y7.92% ROA41.00% Target Price50.20 Perf Year23.17%
Cash/sh1.73 P/C29.23 EPS next 5Y8.30% ROE88.10% 52W Range30.89 - 50.95 Perf YTD40.96%
Dividend0.95 P/FCF22.13 EPS past 5Y20.10% ROI84.70% 52W High-0.98% Beta0.63
Dividend %1.88% Quick Ratio1.00 Sales past 5Y11.00% Gross Margin84.60% 52W Low63.32% ATR0.74
Employees41385 Current Ratio1.30 Sales Q/Q4.30% Oper. Margin44.20% RSI (14)63.30 Volatility1.14% 0.99%
OptionableYes Debt/Eq0.03 EPS Q/Q2.10% Profit Margin33.80% Rel Volume0.63 Prev Close50.55
ShortableYes LT Debt/Eq0.00 EarningsNov 03 BMO Payout63.00% Avg Volume2.01M Price50.45
Recom3.00 SMA202.88% SMA505.26% SMA20023.38% Volume304,112 Change-0.20%
Sep-25-17Downgrade Exane BNP Paribas Outperform → Neutral
Sep-06-17Upgrade BofA/Merrill Underperform → Neutral
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Oct-20-17 05:36PM  Abbvie Inks Immuno-Oncology Deal with Harpoon Therapeutics Zacks
04:36PM  Novo Nordisk Stock: Performance in 3Q17 Market Realist
08:47AM  Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling Zacks
Oct-19-17 03:32AM  Novo Nordisk takes aim at Eli Lilly with U.S. backing of new diabetes drug Reuters
Oct-18-17 05:34PM  Novo Nordisk receives positive 16-0 vote from FDA Advisory Committee in favor of approval for semaglutide PR Newswire
04:59PM  U.S. FDA panel backs approval of Novo Nordisk diabetes drug Reuters
10:17AM  Impax Laboratories and Amneal Pharmaceuticals Agree to Merge Zacks
09:55AM  Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals Zacks
Oct-17-17 03:55PM  Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks Zacks
10:48AM  Sanofi/Regeneron's Dupixent Succeeds in Phase II Study Zacks
10:04AM  Immune Design's Sarcoma Candidate to Enter Phase III in 2018 Zacks
Oct-16-17 06:07PM  Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada Zacks
08:37AM  Novo Nordisk diabetes drug effective, preliminary FDA review finds Reuters
08:09AM  Novo Nordisk diabetes drug effective, no heart risk -FDA review Reuters
Oct-10-17 09:34AM  Why Should You Invest in Novo Nordisk (NVO) Stock Right Now Zacks
Oct-06-17 09:07AM  Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal Zacks
Oct-03-17 08:00AM  Striking Blood Sugar Balance is Critical for Canadians Living with Diabetes PR Newswire
Oct-02-17 06:24PM  Novo Nordisk's Fiasp Gets FDA Nod for Diabetes in Adults Zacks
04:56PM  Why MannKind Corporation Popped Today Motley Fool
09:11AM  Status regarding Novo Nordisk's holding of its own shares (30 September 2017) GlobeNewswire
Sep-29-17 11:16AM  U.S. FDA approves Novo Nordisk fast-acting insulin Fiasp Reuters
11:03AM  Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin PR Newswire
Sep-28-17 09:25AM  Orexigen's (OREX) Contrave Sales Improving on Promotions Zacks
Sep-26-17 12:51PM  Working Mother names Novo Nordisk one of its "100 Best Companies" PR Newswire
Sep-22-17 07:36AM  A Look at Novo Nordisks Hemophilia Franchise after 2Q17 Market Realist
Sep-21-17 10:37AM  How Is Novo Nordisks Victoza Positioned after 2Q17? Market Realist
09:09AM  Xultophy Could Substantially Boost Novo Nordisks Revenue Growth Market Realist
07:39AM  An Update on Novo Nordisks Modern Insulin after 1H17 Market Realist
Sep-20-17 03:37PM  Tresiba Could Boost Novo Nordisks Long-Term Growth Market Realist
02:06PM  Novo Nordisks New Generation Insulins after 1st Half of 2017 Market Realist
12:19PM  How Novo Nordisk Performed in the 1st Half of 2017 Market Realist
10:12AM  Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View Zacks
Sep-19-17 07:00AM  A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd (TEVA) Stock InvestorPlace
Sep-18-17 03:42PM  Novo Nordisk A/S : NVO-US: Dividend Analysis : August 21st, 2017 (record date) : By the numbers : September 18, 2017 Capital Cube
Sep-15-17 01:48PM  Wells Fargo Commercial Mortgage Trust 2016-NXS6 -- Moody's Affirms Seven Classes of WFCM 2016-NXS6 Moody's
Sep-14-17 09:21AM  The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo Nordisk Zacks
Sep-13-17 05:23PM  Top Analyst Reports for Apple, Pfizer & Carnival Zacks
Sep-11-17 04:49PM  Teva Rockets After Hiring Former Novo Nordisk Exec As CEO Investor's Business Daily
01:16PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Soars on New CEO News InvestorPlace
05:47AM  Teva Pharmaceutical Industries Ltd ADR (TEVA) Names Kare Schultz As CEO InvestorPlace
Sep-06-17 10:34AM  Here's Why Novo Nordisk A/S Gained 12% in August Motley Fool
05:14AM  Danish drugmaker reaches settlement with US authorities Associated Press
Sep-05-17 06:21PM  Novo Nordisk settles U.S. probe over diabetes drug for nearly $58.7 mln Reuters
05:10PM  Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices PR Newswire
04:42PM  Novo Nordisk settles U.S. probe over diabetes drug for $58.7 mln Reuters
03:41PM  Novo Nordisk Settles U.S. Suit Over Victoza for $58.65 Million Bloomberg
Aug-29-17 05:21PM  Novo Nordisk's Tresiba Gets Canadian Nod Zacks
07:30AM  Corporate News Blog - Novo Nordisks Victoza(R) Receives Approval from FDA ACCESSWIRE
Aug-28-17 05:57PM  ETFs with exposure to Novo Nordisk A/S : August 28, 2017 Capital Cube
08:30AM  Health Canada Approves Tresiba®, a New Basal Insulin for Type 1 and 2 Diabetes PR Newswire
06:57AM  Novo Nordisk's Victoza Gets FDA Nod for Label Expansion Zacks
Aug-25-17 03:51PM  FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk Reuters
01:42PM  FDA clears Novo Nordisk's diabetes drug to treat heart diseases Reuters
12:18PM  Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events PR Newswire
Aug-22-17 06:30AM  3 High-Yield Pharmaceutical Stocks Motley Fool
Aug-21-17 04:26PM  3 Companies Aiming to Significantly Reduce Diabetes Treatment Costs
10:36AM  Novo Nordisk A/S :NVO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017 Capital Cube
Aug-18-17 07:45AM  The Zacks Analyst Blog Highlights: Pfizer, TJX Companies, Honda, American Electric and Novo Nordisk Zacks
Aug-17-17 06:26PM  Novo Nordisk's Semaglutide Shows Remarkable Results in Study Zacks
05:42PM  Top Analyst Reports for Pfizer, TJX Companies & Honda Zacks
12:17PM  Eli Lilly: Will A New Rival Hobble Its Top Growth Driver?
11:12AM  Novo Nordisk's diabetes drug succeeds in key trial (Aug 16) Reuters
12:44AM  Novo Nordisk's diabetes drug succeeds in key trial Reuters
Aug-16-17 06:36PM  Novo Nordisk's diabetes drug succeeds in key trial Reuters
05:31PM  Novo Nordisk's diabetes drug succeeds in key trial Reuters
12:26AM  [$$] The New Innovators Dilemma: When Customers Wont Pay for Better The Wall Street Journal
Aug-15-17 11:45AM  [$$] When 'New and Improved' Fails: Insulin Maker Stumbles When Customers Balk The Wall Street Journal
10:11AM  The Zacks Analyst Blog Highlights: Deutsche Bank, Novo Nordisk, SINA, Weibo and GOL Linhas Aereas Inteligentes Zacks
09:06AM  Pfizers Important Product Developments in 2Q17 Market Realist
Aug-14-17 04:15PM  Novo Nordisk A/S Continues Its Comeback Motley Fool
10:19AM  Foreign Stock Roundup: Novo Nordisk, GOL Linhas Beat on Earnings Zacks
Aug-11-17 01:01PM  Novo Nordisk (NVO) Beats on Q2 Earnings, Revenues Miss Zacks
Aug-10-17 08:22PM  Novo Nordisk beats 2Q profit forecasts Associated Press
12:24PM  The CEO of the worlds largest diabetes drugmaker says insulin pricing will change it will just be slower than expected Business Insider
10:47AM  Novo Ceo Is Looking at Targets in M&A Hot Space Bloomberg Video
Aug-09-17 04:30PM  Why Red Robin Gourmet Burgers, Hertz Global Holdings, and Novo Nordisk Jumped Today Motley Fool +8.31%
11:57AM  [$$] Novo Nordisk Upbeat on Sales Outlook Despite Flat Earnings The Wall Street Journal
06:42AM  Novo Nordisk raises forecasts despite continued U.S. pressure Reuters
03:45AM  Novo Nordisk Shares Leap Higher After Solid Earnings and Full-Year Sales Upgrade
Aug-08-17 08:45AM  Why Earnings Season Could Be Great for Novo Nordisk (NVO) Zacks
Aug-02-17 04:17AM  Two biggest U.S. drug purchasers keep key Novo Nordisk drugs on 2018 list Reuters
Jul-31-17 10:48AM  Allergan (AGN) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-28-17 03:46PM  High-Quality Stocks: Priceline, Nike, Novo Nordisk
Jul-26-17 11:23AM  Eli Lilly: The Competition is Just Too Darn Intense!
Jul-21-17 08:50AM  Is Novo Nordisk (NVO) Stock a Solid Choice Right Now? Zacks
Jul-19-17 09:23AM  3 Big Pharma Companies With the Best Projected Return on Investment Motley Fool
Jul-12-17 11:05AM  Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management PR Newswire
Jul-10-17 05:33PM  Why Eli Lilly Is Gouging Diabetes Drug Share From Dow's J&J, Others Investor's Business Daily
04:05PM  Performance of Novo Nordisk Stock in 2Q17 Market Realist
Jul-05-17 05:53PM  Novo Nordisk recalls faulty cartridge holders in insulin pens Reuters
03:30PM  Novo Nordisk recalls cartridge holders in certain NovoPen Echo® insulin delivery devices due to potential health risks PR Newswire
10:19AM  Novo Nordisk warns of faulty insulin pens in Canada Reuters
08:16AM  Novo Nordisk warns of risky insulin cartridge holder for some of its NovoPen products MarketWatch
08:05AM  Important safety information for people with diabetes using NovoPen Echo® or NovoPen® 5 CNW Group
Jul-04-17 10:37AM  Johnson & Johnsons Pharmaceuticals Business in 1Q17 Market Realist
12:00AM  Why Big Pharma Is Struggling to Profit From the Obesity Epidemic Bloomberg
Jul-03-17 03:34PM  ETFs with exposure to Novo Nordisk A/S : July 3, 2017 Capital Cube
07:31AM  Status regarding Novo Nordisk's holding of its own shares (30 June 2017) GlobeNewswire
Jun-29-17 12:00PM  The Crazy Math Behind Drug Prices Bloomberg
Jun-26-17 09:30AM  The Zacks Analyst Blog Highlights: Novartis, Roche, Shire, Neos and Novo Nordisk Zacks
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.